Global Cytomegalovirus Retinitis Market 2014-2018

Global Cytomegalovirus Retinitis Market 2014-2018 is a new market research publication announced by Reportstack. Cytomegalovirus retinitis is a viral eye inflammation of the retina. The causative organism of this disease is cytomegalovirus, a herpes virus that attacks the photosensitive cells in the retina. This disease can lead to permanent blindness if left untreated. It affects one eye initially but spreads to the other eye if neglected. The virus is very commonly found in humans but stays dormant. It usually affects a person with weakened immune system such as HIV-positive patients. There are two forms of cytomegalovirus retinitis: indolent form and fulminant form. Some of the common symptoms of cytomegalovirus retinitis are blurred vision, seeing floaters, photophobia, and blind spots.

The analysts forecast that the Global Cytomegalovirus Retinitis market to grow at a CAGR of 4.50 percent over the period 2013-2018. This report covers the present scenario and the growth prospects of the Global Cytomegalovirus Retinitis market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various branded and generic drugs used for the treatment of cytomegalovirus retinitis. Capsules, implants, solutions, and tablets are the four dosage forms of the drugs used for the treatment of cytomegalovirus retinitis.

The report, the Global Cytomegalovirus Retinitis market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Cytomegalovirus Retinitis market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
• APAC
• EMEA
Key Vendors
• F. Hoffmann-La Roche
• Gilead Sciences
• Hospira
• Shire
Other Prominent Vendors

• Auritec Pharmaceuticals
• Chimerix Pharmaceuticals
• Isis Pharmaceuticals
• pSivida
• Sanofi
Market Driver
• Presence of Unmet Needs
• For a full, detailed list, view our report
Market Challenge
• Lack of Approved Treatment Guidelines by the World Health Organization
• For a full, detailed list, view our report
Market Trend
• Increase in Combination Therapies
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?


Companies Mentioned

F. Hoffmann-La Roche, Gilead Sciences, Hospira, Shire, Auritec Pharmaceuticals, Chimerix Pharmaceuticals, Isis Pharmaceuticals, pSivida and Sanofi

To view the table of contents and know more details please visit Global Cytomegalovirus Retinitis Market 2014-2018.